drugset / Trial / NCT01831466

Tofacitinib Ointment For Chronic Plaque Psoriasis

NCT01831466

Phase 2 Completed 476 enrolled Pfizer
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study is beng done to test if tofacitinib ointment is safe and effective for people with plaque psoriasis. Two dose strengths of tofacitinib ointment (20 mg/g and 10 mg/g) applied once or twice daily are being tested. The safety and effectiveness of tofacitinib ointment used for 12 weeks will be compared to the safety and effectiveness of placebo ointment (vehicle) used for 12 weeks.

Timeline

Start
2013-05
Primary completion
2014-09
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Tofacitinib Small molecule 10 unknown Topical
Subject Tofacitinib Small molecule 20 unknown Topical

Indications